Research Solutions, INC Form 4 insider transactions

Sefton Cohen, Chief Revenue Officer of Research Solutions, Inc., reported a transaction in 284,000 shares of common stock on July 31, 2026.

Sefton Cohen, Chief Revenue Officer of Research Solutions, Inc., acquired 80,000 shares of common stock.

Research Solutions CFO David Kutil reported acquiring 30,000 stock options and selling 758 shares for tax purposes.

Research Solutions, Inc. Director Kenneth L. Gayron was granted 50,000 options to purchase common stock at an exercise price of $3.07, vesting over time.

Research Solutions Director Merrill A. McPeak exercised 75,000 options and received a new grant of 50,000 options, increasing his direct beneficial ownership of common stock.

Research Solutions Director John J Regazzi exercised options to acquire 150,000 shares of common stock at $0.70 per share.

Research Solutions Director John J. Regazzi was granted 60,000 options to purchase common stock at an exercise price of $3.07, vesting over time.

Jeremy Murphy, a Director at Research Solutions, Inc., reported the acquisition of 50,000 options to purchase common stock at an exercise price of $3.07.

Research Solutions, Inc. Director Barbara J. Cooperman received a grant of 50,000 stock options with an exercise price of $3.07, vesting over several years.

Research Solutions, Inc. CFO William Nurthen disposed of 2,225 common shares to satisfy tax obligations on vested restricted stock.

Research Solutions, Inc. CEO Roy W. Olivier disposed of 1,428 common shares to cover tax liabilities on vested restricted stock.

Research Solutions, Inc.'s Chief Operating Officer, Scott Ahlberg, disposed of 933 shares of common stock to cover tax obligations on vested restricted stock.

Research Solutions, Inc. CEO and President Roy W. Olivier disposed of 2,126 shares of common stock to cover tax liabilities related to vested restricted stock, as detailed in a recent SEC Form 4 filing.

Research Solutions, Inc. CFO and Secretary, William Nurthen, reported the disposition of 2,909 shares of common stock to cover tax liabilities on vested restricted stock.

Merrill A. McPeak, a Director at Research Solutions, Inc., exercised options to acquire 75,000 shares of common stock at $1.10 per share, increasing his direct beneficial ownership to 409,608 shares.

John J. Regazzi, a Director at Research Solutions, Inc. (RSSS), reported exercising options to acquire 46,000 shares of common stock, significantly increasing his direct beneficial ownership.

Merrill A. McPeak, a Director at Research Solutions, Inc. (RSSS), exercised 50,000 stock options at $1.05 per share, increasing his direct beneficial ownership of common stock to 334,608 shares.

CEO and President of Research Solutions, Roy Olivier, sold shares to cover taxes on vested restricted stock on March 20, 2025.

Scott Ahlberg, COO of Research Solutions, Inc., sold 21,980 shares of common stock on March 20, 2025, to cover taxes on vested restricted stock.

Sefton Cohen, Chief Revenue Officer of Research Solutions, Inc., sold shares to cover taxes on vested restricted stock.

William Nurthen, CFO of Research Solutions, Inc., sold shares to cover taxes on vested restricted stock, as approved by the company's Compensation Committee.

Research Solutions CEO, Olivier Roy, sold 1,986 shares of common stock to cover taxes on vested restricted stock.

Research Solutions CFO William Nurthen sold 2,204 shares of common stock to cover taxes on vested restricted stock.

Research Solutions Inc.'s Chief Revenue Officer, Sefton Cohen, sold 24,981 shares of common stock to cover taxes on vested restricted stock.

Research Solutions Inc.'s Chief Operating Officer, Scott Ahlberg, sold 919 shares of common stock to cover taxes on vested restricted stock.

Research Solutions Inc.'s Chief Revenue Officer, Sefton Cohen, was granted 340,000 shares of restricted stock with vesting conditions tied to the company's stock price.

Barbara J. Cooperman, a director at Research Solutions, Inc., acquired 50,000 stock options on November 12, 2024.

Director Merrill A. McPeak acquired 50,000 stock options in Research Solutions, Inc. on November 12, 2024.

Kenneth L. Gayron, a director at Research Solutions, Inc., acquired 50,000 stock options on November 12, 2024.

Research Solutions director John J. Regazzi acquired 60,000 stock options on November 12, 2024, according to a recent SEC filing.